Erik E. L. Jansen

1.8k total citations
29 papers, 328 citations indexed

About

Erik E. L. Jansen is a scholar working on Oncology, Epidemiology and Obstetrics and Gynecology. According to data from OpenAlex, Erik E. L. Jansen has authored 29 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 19 papers in Epidemiology and 5 papers in Obstetrics and Gynecology. Recurrent topics in Erik E. L. Jansen's work include Cervical Cancer and HPV Research (19 papers), Global Cancer Incidence and Screening (16 papers) and Colorectal Cancer Screening and Detection (7 papers). Erik E. L. Jansen is often cited by papers focused on Cervical Cancer and HPV Research (19 papers), Global Cancer Incidence and Screening (16 papers) and Colorectal Cancer Screening and Detection (7 papers). Erik E. L. Jansen collaborates with scholars based in Netherlands, Germany and Slovenia. Erik E. L. Jansen's co-authors include Inge M.C.M. de Kok, Anita Jansen, Sandra Mulkens, Clare A. Aitken, Harry J. de Koning, Steffie K. Naber, Iris Lansdorp‐Vogelaar, Eveline A.M. Heijnsdijk, Nicolien T. van Ravesteyn and Elisabeth F.P. Peterse and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Carbohydrate Polymers and British Journal of Cancer.

In The Last Decade

Erik E. L. Jansen

28 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik E. L. Jansen Netherlands 10 172 132 69 48 41 29 328
Ayla Açıkgöz Türkiye 10 50 0.3× 77 0.6× 58 0.8× 84 1.8× 23 0.6× 50 324
Lina Titievsky United States 10 35 0.2× 57 0.4× 28 0.4× 50 1.0× 19 0.5× 17 338
Hüseyin Can Türkiye 9 85 0.5× 60 0.5× 19 0.3× 17 0.4× 13 0.3× 38 242
Günter Jantschek Germany 8 47 0.3× 190 1.4× 127 1.8× 40 0.8× 22 0.5× 14 453
Lahiru Russell Australia 12 164 1.0× 22 0.2× 92 1.3× 84 1.8× 21 0.5× 23 355
Marcia Kapari United Kingdom 6 220 1.3× 64 0.5× 49 0.7× 88 1.8× 10 0.2× 7 317
Jennifer Priaulx United Kingdom 9 72 0.4× 37 0.3× 33 0.5× 20 0.4× 9 0.2× 12 265
F.D. Petrariu Romania 9 35 0.2× 27 0.2× 45 0.7× 33 0.7× 8 0.2× 52 288
Miyako Tsuchiya Japan 13 157 0.9× 45 0.3× 44 0.6× 168 3.5× 11 0.3× 36 383
Qiuming Shen China 9 54 0.3× 55 0.4× 49 0.7× 43 0.9× 8 0.2× 26 263

Countries citing papers authored by Erik E. L. Jansen

Since Specialization
Citations

This map shows the geographic impact of Erik E. L. Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik E. L. Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik E. L. Jansen more than expected).

Fields of papers citing papers by Erik E. L. Jansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik E. L. Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik E. L. Jansen. The network helps show where Erik E. L. Jansen may publish in the future.

Co-authorship network of co-authors of Erik E. L. Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of Erik E. L. Jansen. A scholar is included among the top collaborators of Erik E. L. Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik E. L. Jansen. Erik E. L. Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jansen, Erik E. L., et al.. (2025). Should the age range of the Dutch hrHPV‐based cervical cancer screening program be broadened? A modelling study using cohort effects. International Journal of Cancer. 157(4). 627–633. 1 indexed citations
3.
Jansen, Erik E. L., Bronwen R. McCurdy, Rachel Kupets, et al.. (2025). Optimizing the Harms and Benefits of Cervical Screening in a Partially Vaccinated Population in Ontario, Canada: A Modeling Study. Medical Decision Making. 45(5). 545–556. 1 indexed citations
4.
Burger, Emily A., Erik E. L. Jansen, James Killen, et al.. (2025). Disparities in cervical cancer elimination time frames in the United States: a comparative modeling study. JNCI Journal of the National Cancer Institute. 117(7). 1498–1502. 2 indexed citations
5.
6.
Kulasingam, Shalini, Inge M.C.M. de Kok, Erik E. L. Jansen, et al.. (2025). Estimated Cancer Risk in Females Who Meet the Criteria to Exit Cervical Cancer Screening. JAMA Network Open. 8(3). e250479–e250479. 2 indexed citations
7.
8.
Dobruchowska, Justyna M., Justyna Cybulska, Artur Zdunek, et al.. (2024). Associating structural characteristics to immunomodulating properties of carrot rhamnogalacturonan-I fractions. Carbohydrate Polymers. 347. 122730–122730. 4 indexed citations
9.
10.
Jansen, Erik E. L., et al.. (2022). Shift in harms and benefits of cervical cancer screening in the era of HPV screening and vaccination: a modelling study. BJOG An International Journal of Obstetrics & Gynaecology. 129(11). 1862–1869. 6 indexed citations
11.
Jansen, Erik E. L., et al.. (2022). Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study. BMC Medicine. 20(1). 433–433. 9 indexed citations
12.
Gini, Andrea, Nicolien T. van Ravesteyn, Erik E. L. Jansen, et al.. (2021). The EU-TOPIA evaluation tool: An online modelling-based tool for informing breast, cervical, and colorectal cancer screening decisions in Europe. Preventive Medicine Reports. 22. 101392–101392. 10 indexed citations
13.
Jonge, Lucie de, Erik E. L. Jansen, Elisabeth F.P. Peterse, et al.. (2021). Effects of cancer screening restart strategies after COVID-19 disruption. British Journal of Cancer. 124(9). 1516–1523. 53 indexed citations
14.
Jansen, Erik E. L., et al.. (2021). Reducing unnecessary referrals for colposcopy in hrHPV-positive women within the Dutch cervical cancer screening programme: A modelling study. Gynecologic Oncology. 160(3). 713–720. 21 indexed citations
15.
Gini, Andrea, Carlo Senore, Ahti Anttila, et al.. (2021). Development and Validation of Three Regional Microsimulation Models for Predicting Colorectal Cancer Screening Benefits in Europe. MDM Policy & Practice. 6(1). 3444633486–3444633486. 10 indexed citations
16.
Jonge, Lucie de, Erik E. L. Jansen, Elisabeth F.P. Peterse, et al.. (2021). Correction: Effects of cancer screening restart strategies after COVID-19 disruption. British Journal of Cancer. 125(1). 145–145. 1 indexed citations
17.
Smith, Megan A., Emily A. Burger, Alejandra Castañón, et al.. (2021). Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis. Preventive Medicine. 151. 106623–106623. 30 indexed citations
18.
Jansen, Erik E. L., et al.. (2020). The optimal HPV-screening protocol in Eastern-Europe: The example of Slovenia. Gynecologic Oncology. 160(1). 118–127. 6 indexed citations
19.
Jonge, Lucie de, Erik E. L. Jansen, Elisabeth F.P. Peterse, et al.. (2020). Effects of cancer screening restart strategies after COVID-19 disruption. European Journal of Cancer. 138. S16–S16. 4 indexed citations
20.
Jansen, Erik E. L., Sandra Mulkens, & Anita Jansen. (2011). Tackling childhood overweight: treating parents exclusively is effective. International Journal of Obesity. 35(4). 501–509. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayla Açıkgöz Breakdown of academic impact, for papers by Lina Titievsky Breakdown of academic impact, for papers by Hüseyin Can Breakdown of academic impact, for papers by Günter Jantschek Breakdown of academic impact, for papers by Lahiru Russell Breakdown of academic impact, for papers by Marcia Kapari Breakdown of academic impact, for papers by Jennifer Priaulx Breakdown of academic impact, for papers by F.D. Petrariu Breakdown of academic impact, for papers by Miyako Tsuchiya Breakdown of academic impact, for papers by Qiuming Shen
Rankless by CCL
2026